课题基金 / 基金详情

Pathogenesis and epileptogenicity in tuberous sclerosis and focal cortical dysplasia

Pathogenesis and epileptogenicity in tuberous sclerosis and focal cortical dysplasia
结节性硬化症和局灶性皮质发育不良的发病机制和致癫痫性
批准号:
13670831
负责人:
MIZUGUCHI Masashi
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003

项目摘要

项目成果

MIZUGUCHI Masashi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Two types of epileptogenic foci, cortical tubers of tuberous sclerosis (TS) and lesions of focal cortical dysplasia (FCD), show similar histopathologic findings. Using cerebral tissue materials obtained by surgery or necropsy, we compared the immunopathologic features of TS and FCD. First, the expression of protein products of the genes responsible for TS, hamartin and tuberin, was studied immunohistochemically. In the cortical tubers of TS, immunoreactivities for these proteins were weak in normal sized neurons and glial cells, and moderate in abnormal giant cells. In the FCD lesions, immunoreactivities of normal sized cells were comparable to control tissues, and many abnormal giant cells were strongly positive for tuberin. Next, the expression of proteins regulating neuronal migration, doublecortin and fukutin, was studied. Some abnormal giant cells showed an overdue expression of these fetal proteins, the number of which was larger in TS than in FCD. However, the expression levels were highly variable among patients, lesions and cells, excluding clear distinction between TS and FCD based on immunohistochemical findings alone.Many of the TS-associated tumors in the kidneys and heart result from loss of heterozygosity (LOH) involving either the TSC1 or TSC2 gene. By contrast, previous studies have failed to detect LOH in most cortical tubers. Using a cortical tuber of the Eker rat, an animal model of TS, we examined the Tsc2 gene status of individual cytomegalic neurons, by microdissection and nested PCR. The results indicated the absence of LOH in the cytomegalic neurons, demonstrating that the pathogenesis of corticaltubers is different from that of TS-associated tumors.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
Mizuguchi, M., et al.: "Absence of allelic loss in cytomegalic neurons of cortical tuber in the Eker rat model of tuberous sclerosis."Acta Neuropathologica. 107(1). 47-52 (2004)
Mizuguchi, M. 等人:“结节性硬化症 Eker 大鼠模型中皮质结节的巨细胞神经元不存在等位基因丢失。”《神经病理学报》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mizuguchi, M., et al.: "Loss of doublecortin in heterotopic graymatter of a fetus with subcortical laminar heherotopia"Neurology. 59(1). 143-144 (2002)
Mizuguchi,M.,等人:“皮质下层状异位胎儿异位灰质中双皮质素的丢失”神经病学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mizuguchi, M., et al.: "Neuropathology of tuberous sclerosis"Brain and Development. 23(7). 508-515 (2001)
Mizuguchi, M., et al.:“结节性硬化症的神经病理学”大脑与发育。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
水口雅: "発達障害医学の進歩13"診断と治療社. 92 (2001)
水口胜:《发育障碍医学进展13》诊断和治疗株式会社92(2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Interface of neural activity, immunity and metabolism in acute encephalopathy
    • 批准号:
      15H04872
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.23万
    • 财政年份:
      2015
    • 负责人:
      MIZUGUCHI Masashi
    • 依托单位:
    Prevention of autism by drug therapy targeting mTOR system in developing brain
    • 批准号:
      26670491
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.25万
    • 财政年份:
      2014
    • 负责人:
      MIZUGUCHI Masashi
    • 依托单位:
    Crosstalk between serotonin and mTOR systems: molecular pathology in autism and its treatment
    • 批准号:
      24659490
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      MIZUGUCHI Masashi
    • 依托单位:
    Comprehensive gene analysis of acute encephalopathy to elucidate its variability and commonality
    • 批准号:
      24390258
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.48万
    • 财政年份:
      2012
    • 负责人:
      MIZUGUCHI Masashi
    • 依托单位:
    海外基金